Heart Failure

Chicago, IL—A blood test for galectin-3, a unique protein that binds to carbohydrates known as “beta-galactosides,” appears to be a reliable predictor of incident heart failure (HF) and of the response to treatment for HF, reported Jennifer E. Ho, MD, a practicing cardiologist in San Francisco, CA, using data from the National Heart, Lung, and Blood Institute’s Framingham Heart Study, at the 2012 American College of Cardiology meeting.

Chicago, IL—A phase 2 study of autologous bone marrow–cell therapy in patients with chronic ischemic heart disease and left-ventricular dysfunction showed no significant differences for the primary end points, but there were hints of benefit from the prespecified exploratory analyses that point to refinements for future studies that will build on these results, according to the study’s lead investigator, Emerson C. Perin, MD, PhD, Director of Clinical Research for Cardiovascular Medicine, Texas Heart Institute, Houston.


Results 1 - 2 of 2
  •  Association for Value-Based Cancer Care
  • Oncology Practice Management
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Rheumatology Practice Management
  • Urology Practice Management
  • Lynx CME